GlobeNewswire (May 8, 2013)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
GlobeNewswire (May 7, 2013)
-
Raptor Pharmaceutical's PROCYSBI™ Receives FDA Approval for the Treatment of Nephropathic CystinosisPR Newswire (Apr 30, 2013)
-
GlobeNewswire (Feb 26, 2013)
-
GlobeNewswire (Feb 5, 2013)
To learn more about Seeking Alpha Pro, click here.
-
Raptor Pharmaceuticals: An Interview With ThinkEquityBen Yoffe • Mon, Aug 20, 2012
-
Raptor Pharmaceuticals Provides Update On Lead Candidate: RP103Steven Breazzano • Mon, Oct 31, 2011
-
Raptor Pharmaceuticals: A Pipeline With PotentialTony Pelz • Thu, Oct 7, 2010
-
Raptor Pharma CEO Starr Discusses the Changing World of BiotechThe Burrill Report • Mon, Jan 18, 2010
-
Monday Options Brief: JCP, RPTP & WTRInteractive Brokers • Mon, Dec 24, 2012
-
5 Biotechs With January FDA Decision Date CatalystsDavid Zanoni • Mon, Dec 17, 2012
-
Canaccord Genuity Rates These 8 Healthcare Stocks A BuyKapitall • Tue, Jan 31, 2012
-
Hedge Funds Are Buying Up These 20 Healthcare StocksKapitall • Thu, Jan 26, 2012
-
5 Institutional Stock Picks Releasing Earnings Next WeekKapitall • Wed, Jan 4, 2012
-
GlobeNewswire (May 8, 2013)
-
GlobeNewswire (May 7, 2013)
-
Raptor Pharmaceutical's PROCYSBI™ Receives FDA Approval for the Treatment of Nephropathic CystinosisPR Newswire (Apr 30, 2013)
-
GlobeNewswire (Feb 26, 2013)
-
GlobeNewswire (Feb 5, 2013)
-
GlobeNewswire (Dec 21, 2012)
-
GlobeNewswire (Dec 20, 2012)
-
GlobeNewswire (Nov 14, 2012)
-
GlobeNewswire (Nov 9, 2012)
-
GlobeNewswire (Nov 5, 2012)
-
GlobeNewswire (Nov 1, 2012)
-
GlobeNewswire (Oct 10, 2012)
-
GlobeNewswire (Sep 10, 2012)
-
GlobeNewswire (Aug 30, 2012)
-
GlobeNewswire (Aug 7, 2012)
-
GlobeNewswire (Jul 30, 2012)
-
GlobeNewswire (Jul 11, 2012)
RPTP vs. ETF Alternatives
Company Description
Currently, there's no company description for RPTP.










